LLLegha Lotfollahi

Legha Lotfollahi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Legha Lotfollahi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Ilad Alavi Darazam

    Department of Infectious Diseases and Tropical Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Amir Ahamd Nassiri

    Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Tehran, Iran

    1 shared publication
  • Arman Ahmadzadeh

    Department of Rheumatology, Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran

    1 shared publication
  • Azam Rahimzadeh Kalaleh

    Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Tehran, Iran

    1 shared publication
  • Farid Javandoust Gharebagh

    Infectious Diseases and Tropical Medicine Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

    1 shared publication
  • Farid Javandoust Gharehbagh

    Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    1 shared publication

Latest Publications

  • Open Access

    Acute Acalculous Cholecystitis as the First Manifestation of Systemic Lupus Erythematosus in a Young Man: A Case Report and Review of Literature

    by Mohammad Mehdi Shadravan, Arman Ahmadzadeh, Ilad Alavi Darazam, Shahriar Nikpour, Maryam Haghighi Morad, Farid Javandoust Gharebagh, Sadaf Mahmoodkalaye, Setareh Mahmoodi, Legha Lotfollahi

    Acute acalculous cholecystitis can rarely be the initial manifestation of systemic lupus erythematosus. Awareness of this atypical presentation is essential to avoid unnecessary surgical intervention. Prompt recognition and initiation of immunosuppressive therapy may resolve symptoms and help establish the correct underlying diagnosis.

  • Open Access

    The correlation of perirenal fat and atherosclerosis: A systematic review and meta-analysis

    by Melika Golmohammadi, Parynaz Parhizgar, Farid Javandoust Gharehbagh, Legha Lotfollahi

    Objective: Finding accessible diagnostic tools for the diagnosis of atherosclerosis is necessary due to its rising incidence rate. The correlation of perirenal fat thickness (PRFT) and atherosclerosis has been investigated in previous studies using different imaging modalities including ultrasound and CT-scan, but their results have been equivocal. Therefore, we performed a systematic review and meta-analysis of observational studies to determine this potential correlation. Methods: This study is a systematic review and meta-analysis of observational studies. A comprehensive search was conducted up to 2 July 2024, across articles published in the Scopus, Web of Science, Cochrane Library, and PubMed databases. The protocol for this research has been registered in the PROSPERO international database under registration number CRD42024532843. Articles that examined the association between perirenal fat and atherosclerosis, and reported correlation coefficients (r), beta coefficients (β), and odds ratios (ORs) in cross-sectional and case-control designs, involving adult or pediatric human populations, were included. The pooled ORs (95% CI), the log OR, and its standard error were calculated. Results: Following the identification of 10 eligible articles, meta-analysis and subgroup analysis were performed for different conditions, including adults, children, gender, atherosclerosis site, and comorbidity. One study reported the association between perirenal fat weight and atherosclerosis, while the remaining articles measured PRFT. The pooled estimated OR among 4767 adults was 1.24 (1.06–1.45) with I² = 83.6%. Among 929 adults, the pooled correlation coefficient (r) was 0.412 (p < 0.0001, I² = 63.3%). Among 1221 children, it was 0.291 (p < 0.0001, I² = 0%). Conclusion: PRFT is significantly associated with carotid intima-media thickness, suggesting its potential as a non-invasive biomarker of atherosclerosis. Further large-scale, longitudinal studies are needed to confirm its predictive value.


    • 1 May 2018
      • Vol. 12  (3) , 185-189

    Blood Pressure Measurement and Left Ventricular Mass Index in Hemodialysis Patients Comparison of Several Methods

    by Amir Ahamd Nassiri, Legha Lotfollahi, Neda Behzadnia, Ilad Alavi Darazam, Monir Sadat Hakemi, Azam Rahimzadeh Kalaleh, Mina Kamalkhani

    Introduction. Systemic arterial hypertension is prevalent in endstage renal disease and is closely associated with left ventricular hypertrophy (LVH). Blood pressure (BP) behavior is unique in this population, and it is not clear which BP measurement should be used for treatment guidance. We aimed to evaluate the association of several methods of BP measurement with left ventricular mass index (LVMI) as hypertensive end-organ damage. Materials and Methods. Patients on maintenance hemodialysis, 3 or 4 times per week for at least 3 months, were enrolled. We compared the diagnostic value of 6 different methods of BP measurement, including predialysis, postdialysis, interdialysis, and standard BP measurements as well as ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring, based on LVMI as the gold standard. Results. Twenty patients, including 9 women and 11 men were enrolled. Ten patients (50%) had LVH and the others had normal LVMI (LVMI > 100 g/m(2) for women and > 131 100 g/m(2) for men). Only predialysis and postdialysis systolic BP values were significantly associated with LVMI (P = .02 and P = .02, respectively). Conclusions. Predialysis and postdialysis systolic BP values maybe reliable for detecting hypertension in hemodialysis patients, although according to previous data, the importance of self and ambulatory BP monitoring could not be overlooked.